S R Ytterberg

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Viral arthritis
    S R Ytterberg
    Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Curr Opin Rheumatol 11:275-80. 1999
  2. ncbi request reprint Treatment of refractory polymyositis and dermatomyositis
    Steven R Ytterberg
    Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Curr Rheumatol Rep 8:167-73. 2006
  3. doi request reprint Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Steven R Ytterberg
    Rheumatology Division, Mayo Clinic, Rochester, MN, USA
    Joint Bone Spine 76:440-3. 2009
  4. ncbi request reprint Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases
    John M Davis
    Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota 55905, USA
    Medicine (Baltimore) 84:208-17. 2005
  5. ncbi request reprint Genetic and environmental risk factors for idiopathic inflammatory myopathies
    Ann M Reed
    Division of Pediatric Rheumatology, Departments of Pediatrics and Internal Medicine, Mayo Clinic Rochester, Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA
    Rheum Dis Clin North Am 28:891-916. 2002
  6. ncbi request reprint Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota
    Floranne C Wilson
    Division of Rheumatology, Mayo Clinic, College of Medicine, Rochester, Minnesota 55905, USA
    J Rheumatol 35:445-7. 2008
  7. ncbi request reprint Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)
    Philip Seo
    Johns Hopkins University, Baltimore, Maryland
    Arthritis Rheum 52:2168-78. 2005
  8. pmc Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial
    Karina A Keogh
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Am J Respir Crit Care Med 173:180-7. 2006
  9. ncbi request reprint 61-year-old man with dyspnea and bilateral foot drop
    Lee D Cranmer
    Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:363-6. 2002
  10. ncbi request reprint 37-year-old woman with headache
    Nicole M Orzechowski
    Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 81:1393-6. 2006

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Viral arthritis
    S R Ytterberg
    Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
    Curr Opin Rheumatol 11:275-80. 1999
    ..Studies of rheumatic syndromes associated with other viral infections, including alphaviruses, rubella, hepatitis C, and retroviruses, suggest differing mechanisms of host interaction with the infectious agents to cause disease...
  2. ncbi request reprint Treatment of refractory polymyositis and dermatomyositis
    Steven R Ytterberg
    Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Curr Rheumatol Rep 8:167-73. 2006
    ..Better understanding of the underlying pathophysiology of PM and DM, as well as carefully performed multicenter clinical trials is going to be necessary to make better recommendations in the future...
  3. doi request reprint Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Steven R Ytterberg
    Rheumatology Division, Mayo Clinic, Rochester, MN, USA
    Joint Bone Spine 76:440-3. 2009
    ..Collectively, this review shows that more research is needed to provide a firmer body of evidence to support clinical decision-making for patients with vasculitis...
  4. ncbi request reprint Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases
    John M Davis
    Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota 55905, USA
    Medicine (Baltimore) 84:208-17. 2005
    ..This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described...
  5. ncbi request reprint Genetic and environmental risk factors for idiopathic inflammatory myopathies
    Ann M Reed
    Division of Pediatric Rheumatology, Departments of Pediatrics and Internal Medicine, Mayo Clinic Rochester, Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA
    Rheum Dis Clin North Am 28:891-916. 2002
    ....
  6. ncbi request reprint Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota
    Floranne C Wilson
    Division of Rheumatology, Mayo Clinic, College of Medicine, Rochester, Minnesota 55905, USA
    J Rheumatol 35:445-7. 2008
    ..To determine the incidence and prevalence of sporadic inclusion body myositis (sIBM) and polymyositis (PM) in a population-based study...
  7. ncbi request reprint Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)
    Philip Seo
    Johns Hopkins University, Baltimore, Maryland
    Arthritis Rheum 52:2168-78. 2005
    ..To analyze damage occurring in patients with Wegener's granulomatosis (WG) enrolled in the WG Etanercept Trial (WGET) and to correlate that damage with disease activity, adverse events, and quality of life...
  8. pmc Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial
    Karina A Keogh
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Am J Respir Crit Care Med 173:180-7. 2006
    ..Their depletion has been proposed as salvage therapy for refractory disease. Earlier encouraging reports are confounded by concomitant immunosuppressive medications and include only limited available biomarker data...
  9. ncbi request reprint 61-year-old man with dyspnea and bilateral foot drop
    Lee D Cranmer
    Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:363-6. 2002
  10. ncbi request reprint 37-year-old woman with headache
    Nicole M Orzechowski
    Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 81:1393-6. 2006
  11. pmc An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity
    Emily C Baechler
    University of Minnesota Medical School, Minneapolis, MN 55455, USA
    Mol Med 13:59-68. 2007
    ..These data suggest that the IFN signature may be a useful marker for DM disease activity, and that sampling peripheral blood may be a more practical alternative to muscle biopsy for measuring this signature...
  12. ncbi request reprint Herpes zoster in immunocompromised patients: incidence, timing, and risk factors
    Peter K Wung
    Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    Am J Med 118:1416. 2005
    ..To evaluate the risk factors for herpes zoster as well as the incidence and timing of this complication in patients who were treated with immunosuppression because of active Wegener's granulomatosis...